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ABSTRACT 
 
Giardia duodenalis is an intestinal protozoal parasite capable of causing both 
clinical and subclinical disease in a broad range of species, including humans 
and cats. The parasite has a ubiquitous distribution and infection occurs 
worldwide in nearly all mammals. Giardia infection in cats may not be 
associated with any clinical signs, but affected cats most commonly exhibit 
acute small bowel diarrhea with or without weight loss. Estimates of the 
prevalence in cats fall within a broad range (between 1-10%), with higher rates 
generally reported for group housed cats.  
 
Confusion exists regarding the significance of Giardia in cats and the need for 
surveillance and treatment of cats in animal shelters as data regarding the 
zoonotic potential of Giardia-infected cats are lacking.  Cysts of the various 
genotypes are morphologically indistinguishable by light microscopy and 
advanced molecular techniques are required to determine their assemblage 
type. Little information exists regarding the differences among the various 
assemblages, with the principal distinction being host range and possibly 
geographic location. Assemblages A and B have the widest host range and 
cause disease in humans. Assemblages C and D are found mainly in dogs, E 
in livestock, F in cats, and G in rodents. Mixed infections are possible.  
 
The purpose of this study was to estimate the prevalence of Giardia in cats 
available for adoption at an animal shelter in central New York, assess 
zoonotic risk by determining the assemblage type(s) found in cats shedding 
Giardia cysts, and determine risk factors for infection.  Once monthly for 5 
 3
months a single fecal sample was collected from all cats available for 
adoption; samples were tested for the presence of Giardia antigen using a 
commercially available ELISA and all ELISA positive samples were processed 
for genotype analysis.   
 
There was significant variation in the overall prevalence of Giardia from month 
to month, with more than a two-fold increase between spring (April, May: 
6.7%) and summer months (June, July, August: 13%).  Stray adult cats and 
those with outdoor access were more likely to be infected than owner-
surrendered cats and those that were kept indoors only.  Among adult cats, 
increasing age was associated with decreasing risk of Giardia infection. Cats 
in colony housing, particularly at high densities and for prolonged periods of 
time, were also more likely to be shedding Giardia cysts.  
 
A total of 61 fecal samples that tested ELISA positive for Giardia were 
submitted for molecular analysis.  Both zoonotic and host-adapted 
assemblages were identified; 75% of samples were the host-adapted 
assemblage F while 25% of samples (assemblages A and B) had zoonotic 
potential based on reported host ranges. Cats with potentially zoonotic 
assemblages were significantly more likely to be adults and to have soft stools 
or diarrhea than those cats infected with the host-adapted genotype. These 
results confirm that cats can not be discounted as a potential source of human 
Giardia infection, but identification of cats that pose a risk is not possible 
without advanced molecular diagnostics.  Despite a greater understanding of 
the molecular epidemiology of the disease, the question as to whether or not 
asymptomatic cats found to be shedding Giardia cysts should be treated in 
order to protect public health cannot be answered. Further work is needed with 
larger numbers of cats, both owned and from animal shelters, from various 
geographic locations to better understand the importance of various risk 
factors and to establish the true zoonotic potential of Giardia. 
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CHAPTER 1 
LITERATURE REVIEW 
Life Cycle and Pathogenesis 
Giardia is an intestinal protozoal parasite capable of causing both clinical and 
subclinical disease in a broad range of species, including humans and cats. 
The organism has a simple, direct life cycle, and transmission occurs via the 
fecal-oral route or through contact with contaminated fomites. Affected animals 
shed infective cysts, which contain two mitotically arrested trophozoites that 
emerge in the duodenum of animals following ingestion. The trophozoites then 
complete mitotic division, multiply, and attach to the microvilli.  The exact 
mechanisms of how they cause disease have not been fully elucidated, but 
enterocyte apoptosis, villus atrophy, diffuse shortening of microvilli, loss of 
epithelial barrier function, and increased permeability of enterocytes have all 
been reported in Giardia infections.1  One study of Giardia in kittens revealed 
that overall loss of the epithelial brush border surface area was associated 
with experimental infection and 80% (4/5) of those infected developed 
diarrhea. 2 However, because many infections are subclinical and the 
pathologic changes can be found in animals with and without clinical signs, it 
remains unclear as to how such intestinal alterations relate to the 
manifestation of disease.  The development of clinical signs apparently relies 
on a combination of factors, most notably on the host’s immune status.  
Both trophozoites and cysts are excreted in the feces of cats, but the former 
are not infective. To become infective, trophozoites must re-encyst in the 
gastrointestinal tract (in response to intestinal conditions such as an alkaline 
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pH and in the presence of bile salts and fatty acids) through the exocytosis of 
cyst wall antigens that form a filamentous network over their surfaces. 3 These 
small oval to teardrop shaped cysts are then excreted in the feces, where they 
are immediately infective and capable of surviving outside of the 
gastrointestinal tract. Cysts frequently become waterborne and may survive for 
weeks to months in cool, moist environments but are susceptible to drying. 4 
Rapid environmental contamination is likely in animal shelters and catteries 
where endemic disease is present, and cysts can become well-adhered to the 
perianal region of cats, facilitating re-infection and complicating control efforts. 
 
Clinical signs 
The prepatent period ranged from 5-16 days with a median of 9.6 days in one 
study 5  and was reported to average 12 days (range 11-13 days) in another 
investigation. 6 Many cases of Giardia in cats are subclinical, 7 but clinical 
disease is possible and signs may precede cyst shedding by 1-2 days. Cats 
developing signs most commonly exhibit acute small bowel diarrhea, with or 
without weight loss. Disease may be severe in a limited number of cases, and 
large bowel diarrhea, failure to thrive and even vomiting 8 have been described 
in cats shedding Giardia cysts in their feces. Infection may become chronic, 
however some cats clear the infection after several weeks without treatment. 6 
Cyst shedding is cyclical in nature, and the substantial variation in the intensity 
of cyst shedding explains why the number of cysts present in a fecal sample 
does not directly correlate with the severity of infection.  Thus, the clinical 
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significance of finding only a few cysts in a fecal sample may be no different 
than finding large numbers. 9,10 
Many clinicians believe that infected cats are more likely to be young, have 
diarrhea, and/or have been recently housed in an animal shelter or cattery, but 
the available research does not consistently support this clinical impression. 
Study results have been mixed, with some investigators reporting that cyst 
shedding is more likely in adults 7 and in cats with normal stools 11,12 while 
others have found an association with younger cats 11, 13-15 and in those with 
diarrhea. 16 Cysts can be found in healthy and diarrheic animals, and the 
presence of Giardia cysts on a fecal examination in a cat with consistent 
clinical signs does not confirm that the clinical disease is a result of Giardia 
infection. The literature suggests that the presence or absence of clinical signs 
is generally not helpful in predicting the infection status of a cat, and in some 
studies, a higher prevalence of intestinal parasites (including Giardia spp., 
Toxocara spp., Toxoplasma gondii, Salmonella spp., Campylobacter jejuni, 
and Cryptosporidium spp.) has been found in cats without diarrhea. 17 
 
Geographic Distribution and Prevalence 
Giardia infection occurs worldwide in nearly all mammals. Estimates of 
prevalence in domestic cats are commonly reported to range between 1 and 
10% 18 but vary greatly because of subclinical infections, variation in diagnostic 
methods, and other factors.   Prevalence rates for catteries have been 
reported to be as high as 50% 7 and prevalence estimates have generally 
been reported to be higher in group-housed animals.   
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Although it is difficult to compare prevalence rates across studies because of 
varying sampling approaches and diagnostic methodologies, recent work 
suggests that the prevalence of Giardia infection varies substantially across 
populations, regardless of the source of cats. There can be substantial 
geographic variation within and between countries, as evidenced by more than 
a 30-fold difference in prevalence between areas of the United States in a 
single study (range 0.1%-3.3% in the mid- and north Atlantic region and 
Mountain region, respectively).15   
In the Niagara Region of Canada, 1 of 41 samples (2.4%) collected from cats 
presented to veterinarians in private practice were positive for Giardia when 
tested with a formalin-ethyl acetate concentration technique at a university 
laboratory.  The same study found a reported prevalence of 0.1% from 5 
veterinary practices completing a mail-in survey that asked the clinics to 
complete a table reporting the frequency of Giardia spp, Cryptosporidium spp, 
and Toxocara spp in dogs and cats over a specified period of time. 19 Zinc 
sulfate (ZnSO4) fecal flotations without centrifugation performed on 211,105 
samples from cats presented to Banfield hospitals across the United States 
revealed a prevalence of 0.58%. 15  A study of 452 cats presented to a 
veterinary teaching hospital in Pennsylvania found a prevalence of 3.5% for 
Giardia when samples were evaluated by ZnSO4 centrifugation flotation. 13  In 
an urban veterinary clinic in England, 35% (7/20) cats were determined to be 
shedding Giardia cysts based on examination of a single fecal sample with a 
significantly higher prevalence (p = 0.02) in cats less than 3 years of age 
compared to those 3 years of age and older. 11  
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When animals exhibiting clinical signs of gastrointestinal disease were 
specifically evaluated, overall prevalence rates tended to be higher compared 
to studies surveying cats regardless of their clinical status. A large national 
study found a prevalence of 10.3% (513/4978) in cats from all regions of the 
United States based on a commercially available enzyme-linked 
immunosorbent assay (ELISA) test (SNAP Giardia Test, IDEXX Laboratories, 
Westbrook, ME.) 3   In Santiago, Chile, investigators found a prevalence of 
19% (44/230) based on fecal flotations for cats presented to veterinarians in 
two private practices. 20 
A large study in western Australia screened 418 cats from varying sources for 
multiple gastrointestinal parasites with fecal flotation techniques and failed to 
identify any cats that were shedding Giardia cysts. 21  However, when a subset 
of 40 cats from this original sample were tested by ELISA and PCR, 60% and 
80% respectively, were found to be positive. 22 Similarly, a prevalence of 40% 
was found using an ELISA in pet cats in Japan. 23  In the southeastern United 
States, a prevalence of 13.6% was found in 250 pet cats screened with IFA 
techniques. Cyst shedding was more common in multiple cat households and 
households where another cat was shedding cysts, in cats with acute or 
chronic gastrointestinal complaints, and in cats less than one year of age. 
Whether the cat was acquired from an animal shelter or not had no effect on 
prevalence. 8 Investigators in North Carolina found 5% (3/66) of pet cats and 
6% (5/87) of feral cats to be shedding Giardia cysts as detected by IFA, with 
no significant difference between the two groups. 23 
Reported prevalence rates were similar in studies that exclusively sampled 
cats at animal shelters or catteries.  In 22 shelters in the Netherlands, only 1% 
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(3/305) of cats were shedding Giardia cysts as detected with a centrifugation-
flotation technique,14 while 9.9% (34/344) of cats in northern California 
shelters were positive based on a direct immunofluorescence assay.16  
Another study investigating the cause of diarrhea in 89 different catteries 
found that 36 of 117 (31%) cats were infected with Giardia based on ELISA 
results; at least one cat was infected in 35% (31/89) of the catteries.24  In 
studies sampling both owned and shelter cats, similar rates of infection were 
found for Giardia. Using ZnSO4 centrifugation-flotation, a study in northern 
Colorado25 found an overall prevalence of Giardia of 2.4% (5/206) in cats with 
and without diarrhea.  Although the shelter cats tended to have higher rates of 
infection with enteric zoonotic organisms overall, the prevalence of Giardia 
was actually lower in shelter cats (1.3%) compared to owned cats (3.1%) in 
this study.  A similar study of 263 feline fecal samples obtained from privately 
owned or shelter cats less than 1 year of age in central New York found an 
overall prevalence of 7.3% (19/263) for Giardia using the same diagnostic 
methods.17 There was no difference in prevalence for cats from shelters 
(12/149) compared to those presented to private clinics (7/114), however 6 of 
the 7 owned cats who were positive for Giardia had been adopted from an 
animal shelter.  
Based on this information, it is difficult to conclude whether origin itself is a risk 
factor for Giardia infection in cats.  However, conditions that may be found in 
some shelters (e.g. group housing, high density) and prolonged time living in 
such conditions have been associated with higher rates of disease. Gookin 
reported high housing densities, the presence of cats with diarrhea, and 
contact with non-feline species as risk factors for Giardia infection 24 while 
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Cirak demonstrated that length of residence in shelters was associated with an 
increased risk of Giardia infection. 26 This work suggests that the longer a cat 
spends in a facility where other cats are infected with Giardia, particularly 
when there is crowding, the greater the risk of infection with Giardia. 26 Other 
studies have found that the main preventive factor against parasitic infection in 
general was a short stay in the shelter. 14 Additional research is needed in 
order to better elucidate and define the relationship between shelter conditions 
and the risk of Giardia infection in cats as well as the best practices to limit 
infection of cats in animal shelters. 
 
Diagnosis 
Even with numerous options for testing, Giardia presents a diagnostic 
challenge and is generally considered to be underdiagnosed. Limitations in 
diagnosis hamper efforts to better understand the epidemiology of Giardia 
infections, as findings can differ substantially as a result of different 
methodologies.  For example, as previously described, one Australian study 
reported a prevalence of 0% in cats using fecal flotation, but 80% of those 
same samples were positive when analyzed by PCR.22 Similarly, an earlier 
study of shelter animals in Germany failed to find Giardia cysts in the feces of 
100 cats, but 22.4% of those same samples were positive when screened with 
a commercially available ELISA test. 26  
Cysts are small (approximately 12um x 7um) and can be difficult to identify on 
fecal flotation even when concentrating techniques are used.  The cysts can 
be confused with pseudoparasites such as yeast or plant matter and are easy 
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to overlook even with careful microscopic inspection of samples. The ZnSO4 
centrifugation-flotation technique (ZNCT) has been considered the gold 
standard for the diagnosis of Giardia when used by trained personnel. 
However, the shedding of cysts is intermittent and as a result at least three 
ZNCTs performed on consecutive fecal samples must be negative in order to 
rule out Giardia infection. Furthermore, many veterinary practitioners are 
unable to successfully identify Giardia cysts when they are present; at a major 
veterinary conference, only 6 of 27 participants in a wet lab were able to 
identify Giardia cysts from a known positive sample. 9,10 While ZnSO4 
centrifugation procedures increase recovery and maintain the integrity of 
cysts, they do not completely alleviate problems associated with cyst 
identification and low numbers of organisms. 
Although multiple ZNCTs have traditionally been considered to be the gold 
standard for the diagnosis of Giardia, ELISA and IFA evaluations are 
increasing in use and acceptance.  ELISAs, including both commercially 
available tests for in-house use as well as those performed by diagnostic 
laboratories, were originally developed for use in humans and are being used 
with increasing frequency in veterinary practice for cats and dogs. Because 
they detect an antigen produced by trophozoites that is shed continuously, 
they theoretically avoid the problem of intermittent cyst shedding and are 
generally easier to interpret than a fecal flotation. While their specificity is high, 
reports on the sensitivity of Giardia ELISA tests vary substantially, ranging 
from 68-95%. One author 27 found an in-house ELISA (SNAP® Giardia Test, 
IDEXX Laboratories, Westbrook, ME) to have 90% sensitivity and 96% 
specificity when compared to immunofluorescence and another investigator 
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found that antigen was regularly detectable via ELISA in Giardia-infected dogs 
and showed good correlation with ZNCT.28 Another study evaluating 344 
samples from cats in 4 different northern California shelters found that the 
IDEXX SNAP® Giardia test was highly sensitive and specific for diagnosis of 
cyst shedding in cats with or without diarrhea and was more sensitive than 
available human test kits.16 False negatives were most common in samples 
with low cyst counts and in diarrheic samples, which may be the result of 
dilution. However, when performed in parallel with fecal flotation the combined 
sensitivity of the two tests was increased to 97.8% on a single sample. 
Direct immunofluorescence (IFA) tests, which use antibodies against Giardia 
to detect and identify cysts, are also available and have been shown to be 
more sensitive than ZNCT in cattle and sheep, particularly when low numbers 
of cysts are present.29 IFA tests are commonly used as the gold standard in 
prevalence studies if not in clinical practice for the diagnosis of Giardia in cats 
and dogs. Genetic heterogeneity does not appear to significantly alter test 
results but may be a possible explanation for the diminished sensitivity that is 
observed when human-validated tests are used in cats. Debate continues over 
which testing protocol is the most accurate, but most experts agree that some 
combination of multiple tests on multiple samples is necessary to minimize 
false negative results.  For example, when used in asymptomatic dogs in 
Finland, false negatives on an ELISA were also found in samples with low cyst 
counts (less than 104 cysts/g of feces) when compared to results obtained with 
IFA testing.  One sample, however, seemed to be sufficient in determining 
infection status based on IFA results (as a very high kappa was noted 
between results from successive samples).30  Based on this information, it is 
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therefore possible that antigen/antibody-based techniques are sensitive 
enough to allow for a reasonable approximation of prevalence on the basis of 
a single sample rather than 3 consecutive samples typically considered 
necessary for ZnSO4 fecal flotation.  This is an important consideration since 
in many instances it may not be feasible to obtain multiple samples from an 
individual animal. 
 
Zoonotic Potential 
In addition to the challenge of identifying Giardia infections in cats, the public 
health significance is unknown, raising questions about the need for identifying 
and treating infected cats. Data on the frequency of zoonotic transmission is 
lacking and is generally based on circumstantial rather than experimental 
observations. In one study, investigators were unable to establish persistent, 
patent infections in kittens (n = 14) after experimental infection with human-
source Giardia cysts and trophozoites.31 In another study, investigators 
evaluated owners and their pets for Giardia and found an overall prevalence of 
13.7% in people, 7.3% in dogs, and 14% in cats but were unable to 
demonstrate an association between human and animal infection. 32 
More recently, efforts have focused on identifying human and animal infections 
using genotyping to improve the understanding of the host specificity and 
clinical disease produced by various Giardia species.  Several Giardia species 
are known to have a limited host range.  For example, Giardia agilis, argeae, 
psittacci, muris, and microti have been shown to infect amphibians, birds, and 
rodents respectively, but not humans.  In contrast, Giardia duodenalis (also 
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known as Giardia intestinalis and Giardia lamblia) has a wide host range and 
probably represents a species complex comprised of a variety of genotypes 
with different host specificities.33,34  The majority of mammalian infections are 
thought to be caused by Giardia duodenalis, which can be divided into several 
morphologically identical, but genetically distinct groups with varying host 
specificities.  
A comprehensive phylogenetic study analyzed Giardia duodenalis isolates at 4 
different genetic loci, confirming the current distinction of seven different 
lineages known as assemblages.35 Cysts of these varying genotypes are 
morphologically indistinguishable by light microscopy and advanced molecular 
techniques are required to determine their assemblage type.  It is important to 
note that inconsistent nomenclature has been used to describe the various 
genotypes, complicating the interpretation of the literature.  For example, 
assemblages A and B have also been referred to as Polish, Belgian, and 
groups 1/2 and 3.36 Human infections are widely considered to result only from 
assemblages A or B, which have the widest host specificity, with the former 
possessing the greatest range. These genotypes can be further broken down 
into subtypes, with assemblage A divided primarily into subtypes A1 and A2 
and assemblage B divided into subtypes B3 and B4. Assemblage A is 
considered to be the most important genotype with regards to zoonotic 
transmission. The other 5 assemblages appear to be far more host adapted, 
with assemblages C and D being found mainly in dogs, E in livestock, F in 
cats, and G in rodents.  Mixed infections are also possible.  
Although assemblage A possesses the widest host specificity, its subtypes 
appear to be more restricted. Most human infections involve subtype A2, while 
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the majority of animal infections involve either subtype A1 or the host-adapted 
genotypes (e.g. assemblage E in livestock, assemblage F in cats, and so 
forth), providing little support for the theory that zoonotic transmission among 
various species is widespread. Although limited, case-control studies have 
largely failed to identify contact with pets as a risk factor for giardiasis in 
children and adults.37 Instead, sanitation and personal hygiene appear to be 
far more important factors for infection, suggesting that zoonotic transmission 
is of little, if any, significance. In fact, some authors 1 have proposed that 
assemblages C, D, E, F, and G be re-categorized as distinct species such as 
Giardia canis, Giardia felis, and Giardia bovis because of their apparently 
limited host range.  It is possible that zoonotic transmission through 
contamination of water sources may exist but such contamination is more 
likely attributable to wildlife (owing to proximity) or livestock (as a result of the 
volume of manure and number of cysts), rather than companion animals such 
as cats and dogs. Even the population of feral cats seems unlikely to 
contaminate water sources given the low prevalence of cyst shedding found 
by Nutter et al. 23 Most likely, the majority of human cases result from direct or 
indirect contact with human-origin Giardia isolates rather than spread from 
animals to people. 
The presence of genotypes with broad host specificity implies that zoonotic 
transmission is possible, but neither verifies its occurrence nor the direction of 
transmission if it occurs. For example, one investigator found a strong 
association between the prevalence of the same assemblages in humans and 
Giardia-positive dogs in the household, but was unable to determine whether 
humans were the source of Giardia circulating in the dogs or vice-versa.38 
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Other studies have failed to find an association with fecal cyst shedding in pets 
and cyst shedding in humans, suggesting that transmission is limited at best 
and of questionable clinical significance. 37   
In order to improve the current understanding of its zoonotic potential, a 
number of studies have focused on determining the assemblage(s) of Giardia 
spp found in cats.  When interpreting these results, however, it is necessary to 
recognize that genotypic differences are determined by PCR amplification of a 
particular gene followed by sequence analysis.  Since different studies have 
analyzed different target genes, there can be a significant degree of 
discrepancy in the assemblage results depending on which genes were 
selected for sequencing. Indeed, studies employing different genotyping tools 
can easily yield vastly different results, and it has been suggested that 
simultaneously screening for several genes would yield more accurate 
determinations of assemblage type. Targets include ssu-rRNA or any number 
of genes, including β-giardin, glutamate dehydrogenase, elongation factor 1-
alpha, triose phosphate isomerase, GLORF-C4, or inter-genomic rRNA spacer 
region.34 These genes vary in their polymorphism as some are much more 
highly conserved among assemblages and species than others. Furthermore, 
published primers do not universally amplify Giardia DNA, possibly as a result 
of greater sequence variability in certain genes when compared to the multi-
copy nature of ssu-rRNA.  Therefore, the assignment of an isolate to one 
assemblage or another can be unreliable, and isolates typed as “potentially 
zoonotic” by one marker might be typed as “species specific” by another 
marker.34 
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Seven studies have attempted to determine which genotypes are found in 
Giardia infected cats to date.  Even with the increasing body of scientific 
literature, assemblage results are only available for a total of 78 cats and 
some studies had sample sizes as small as 3 individuals.  The results have 
varied substantially among studies, with some investigators finding cats to be 
exclusively infected with assemblage A,39 others identifying assemblage F,40-41 
and still others reporting a mixture of assemblages within the populations 
studied.40-43 One study even found that sequencing results for 13 of the 14 cat 
samples were most consistent with a dog-adapted genotype (assemblage D) 
that had not previously been reported in other species.22 It is possible that 
some of these discrepancies are the result of differing methodologies and 
interpretation of sequencing results, while other variation may be attributable 
to geographical differences as the work has been conducted in Italy, the 
United States, Brazil, Columbia, Japan, and Australia.   
Because of the small number of cats studied to date and the wide variation in 
geographical location of the investigations, differences among assemblages 
regarding risk factors for infection or severity of infection have not yet been 
identified. Based on descriptive data in the limited body of work available, it 
appears that assemblage A is more likely to be found in young cats less than 6 
months of age and those with outdoor access39 but further research is needed 
to determine if these characteristics are truly risk factors for infection.  
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Treatment and Public Health Recommendations 
Insufficient data have been collected on the assemblage types found in 
Giardia infected cats to make a quantitative, accurate assessment of the 
public health risk associated with these cats.  Despite a greater understanding 
of the molecular epidemiology of the disease, the question as to whether or 
not asymptomatic cats found to be shedding Giardia cysts should be treated in 
order to protect public health cannot be answered. Data which suggest that 
zoonotic transmission of Giardia from pets to humans is unlikely to be 
significant cause of human cases are accumulating.45 More recent veterinary 
recommendations reflect this belief and do not call for automatic treatment of 
asymptomatic cats and dogs found to be shedding cysts. Indeed, current 
professional guidelines published by the Companion Animal Parasite Council46 
state that dogs and cats should not be treated solely for the purpose of 
preventing zoonotic transmission and that repeated courses of treatment are 
not indicated in dogs or cats without clinical signs.  However, this belief is not 
universally accepted and some experts still call for the treatment of all infected 
companion animals regardless of the presence of clinical disease.32  In fact, 
treatment recommendations vary widely among veterinary experts, public 
health officials,  and basic scientists.  
As such, many animal shelters and veterinarians remained concerned about 
the potential liability associated with failing to identify or electing not to treat 
infected cats. The decision of whether or not to treat is further complicated by 
the fact that many infections in cats are subclinical and no treatment protocols 
have been proven to be 100% efficacious. It is unclear whether drug therapy 
eliminates Giardia infections or merely suppresses cyst shedding, and the 
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efficacy may be further reduced in animals with diarrhea since rapid 
gastrointestinal transit time may result in decreased drug contact with the 
trophozoites.3  Successful clearance of Giardia spp. infection from individual 
cats can thus be difficult, and elimination of endemic disease in feline 
populations is particularly challenging. Even when initial treatment is 
successful at stopping cyst shedding, reinfection from a contaminated facility, 
from other cats, or from a cat’s own hair coat while grooming is common.47  
For these reasons, increased sanitation and disinfection are commonly cited 
as essential factors in eliminating infection from affected facilities.  Giardia 
cysts are destroyed with many disinfectants commonly used in animal holding 
facilities, including sodium hypochlorite (e.g. household bleach) and 
quaternary-ammonium containing products. Cysts are also susceptible to 
desiccation, and ensuring a dry environment can be helpful in breaking the 
cycle of transmission. In addition, bathing cats in order to remove infective 
cysts from their hair coats and then moving them to uncontaminated 
enclosures after they have been treated has been recommended to help break 
the transmission cycle.4  
There are no approved drugs for the treatment of giardiasis in cats. Available 
but unapproved drugs (e.g. extra label usage) include metronidazole, 
albendazole, fenbendazole, and a product containing a combination of 
febantel, pyrantel, and praziquantal (Drontal Plus®, Bayer Animal Health, 
Shawnee Mission, KS). Several studies have examined the efficacy of these 
medications in eliminating the shedding of Giardia cysts in dogs, but only a 
few studies have evaluated their efficacy in cats. Reported efficacies in cats 
range from 50-100% for fenbendazole (n = 8)48 and 20-60% for Drontal Plus® 
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depending on the dosage (n = 16).49 Recently, a study found that 
metronidazole benzoate administered at a dose of 25 mg/kg by mouth twice 
daily eliminated cyst shedding in 100% (n = 26) of study cats,50 but the study 
lacked a control group. A commercially available vaccine has also been 
studied as a possible treatment for Giardia but has neither been demonstrated 
to be an effective treatment nor preventive.51 Some authors have suggested 
concurrent treatment with metronidazole and fenbendazole believing that the 
combination may be more efficacious than treatment with either drug alone, 
however no controlled studies have been performed to evaluate such a 
protocol.46  In addition, it is imperative that steps are taken to improve an 
infected cat’s overall health and immune system, including elimination or 
treatment of concurrent diseases and other parasitic infections, reduction of 
stress, and improved nutrition.    
In addition to concerns of efficacy, there also remains a question of safety 
regarding the treatment protocols for cats. Metronidazole administration has 
been associated with gastrointestinal and central nervous system toxicity, 52 
particularly when used at high doses for long periods of time (e.g. longer than 
1 week).  Albendazole has been shown to cause bone marrow suppression in 
some cases. 53 
 
Summary 
Giardia duodenalis is a common intestinal protozoal parasite capable of 
causing both clinical and subclinical disease in a broad range of species, 
including humans and cats. Cysts of the varying genotypes are 
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morphologically indistinguishable by light microscopy and advanced molecular 
techniques are required to determine their assemblage type. Little is known 
about the differences among various assemblages, but the principal distinction 
appears to be host range and thus zoonotic potential. Confusion exists 
regarding the significance of Giardia in cats and the need for surveillance and 
treatment in animal shelters as both the zoonotic assemblage A and host-
adapted assemblage F have been isolated from cats. Because most infections 
are subclinical and there are no conclusive data that Giardia infected cats 
pose a human health risk, treatment may not always be indicated. The 
decision as to whether or not to treat is further complicated by the fact that 
there are no approved drugs for the treatment of giardiasis in cats and no 
treatment protocols have been proven to be 100% efficacious.  
The confusion surrounding Giardia in cats is particularly evident in animal 
shelter settings. Concerns regarding public health and legal liability have 
prompted some shelters to actively screen the cats in their care for Giardia 
infection, but such practices place a tremendous burden on the already limited 
resources of these organizations and may not be necessary.  Research is 
need in order to better characterize the host range and zoonotic potential of 
various assemblages and to determine risk factors for infection associated 
with them.  Such knowledge would then allow for a more quantitative and 
accurate assessment of the true public health risk associated with Giardia in 
cats and the need for treatment in clinically normal cats.  Elimination of 
endemic infection in feline populations is particularly challenging, and a 
thorough risk assessment would greatly assist veterinarians and humane 
organizations in targeting their diagnostic and therapeutic efforts. 
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This literature review identifies several gaps in existing knowledge regarding 
Giardia infection in shelter cats.  For instance, prevalence estimates vary 
significantly among different populations of cats studied.  Although it has been 
hypothesized that such variation is due, in part, to differences in diagnostic 
methodology and geographic location, there is a general lack of knowledge 
regarding risk factors for infection.  In addition, there may be clinically 
significant but still undetermined factors affecting prevalence.  The pathogenic 
mechanisms remain to be fully elucidated, and little is known about the 
specifics of the host, agent, and environmental factors that determine the 
clinical course of disease or lack thereof.  Optimal testing protocols, based on 
sensitivity, specificity, ease of use and interpretation and cost have yet to be 
established for use in individual cats as well as for feline populations. Finally, 
the true zoonotic potential of Giardia has yet to be established. This paucity of 
knowledge makes evidence-based decision-making difficult if not impossible in 
the clinical setting. In the context of animal shelters, where large numbers of 
cats of varying immune status are housed concurrently and where resources 
for animal care are limited, these challenges are particularly evident. 
The purpose of the study described in the subsequent chapter was to expand 
the existing body of knowledge pertaining to Giardia infections in shelter cats 
and to specifically address the question of its zoonotic potential in order to 
provide data that can be used for quantitative risk assessment. Specifically, 
the study was designed to investigate the following hypotheses:  
(1) The prevalence of Giardia infection in shelter cats is within the range 
reported for owned cats;  
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(2) Most shelter cats are not a public health threat with regards to 
transmission of Giardia to people; 
(3) Conditions that could reasonably be expected to facilitate 
transmission of Giardia (e.g. overcrowding) or increase host 
susceptibility to infection (e.g. age) are risk factors for infection. 
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CHAPTER 2 
Prevalence of, risk factors for, and assemblage types of Giardia spp. 
infection in cats housed in an animal shelter 
Janeczko SD, Griffin B, Barr SC, Santin M, Scarlett JM. 
 
Abstract 
Objective – To estimate the prevalence and zoonotic potential of 
Giardia in cats housed in an animal shelter and to determine risk factors 
for infection. 
Design – Cross-sectional study 
Sample Population – Cats housed in the adoption ward at an animal 
shelter in central New York 
Procedures – Fecal samples were collected once monthly from cats 
available for adoption for 5 months and tested for the presence of 
Giardia antigen with a SNAP® Giardia Test.  PCR and sequencing were 
performed on all positive samples to determine the assemblage of each 
Giardia isolate.   
Results – Monthly prevalence of Giardia infection ranged from 6.6% - 
14.8% with a significantly higher prevalence in the summer than in the 
spring (p = 0.03). Infected cats were more likely to have entered the 
shelter as strays and to have been housed with a greater number of 
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cats than controls. The host-adapted assemblage F was found in 75% 
of infected cats, and potentially zoonotic assemblages A and B were 
found in the remaining 25%. The latter were more commonly identified 
in adults than kittens, and in cats with soft stools or diarrhea.    
Conclusions and Clinical Relevance – Although the prevalence of 
Giardia in cats in this study was slightly higher than in previous reports, 
most infections were not associated with clinical signs and did not have 
zoonotic potential based on reported host ranges.  However, the 
potential for cats to be a source of human Giardia infection can not be 
discounted.  Additional studies are needed to better understand the risk 
factors associated with infection with the various assemblage types and 
to establish its true zoonotic potential. 
 
Introduction 
Giardia duodenalis (also known as Giardia intestinalis and Giardia lamblia) is 
an intestinal protozoal parasite capable of causing both clinical and subclinical 
disease in a broad range of species, including humans and cats. Affected 
animals shed infective cysts containing two mitotically arrested trophozoites 
that emerge in the duodenum following ingestion. Cysts are frequently 
waterborne and may survive for weeks to months in cool, moist environments 
but are susceptible to drying.1 Giardia has a simple, direct life cycle, and 
transmission occurs via the fecal-oral route.  Rapid environmental 
contamination is likely in animal shelters and catteries with endemic disease, 
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and cysts can become well-adhered to the perianal region of cats, facilitating 
infection and re-infection. 
The parasite has a ubiquitous distribution and Giardia infection occurs 
worldwide in nearly all mammals. Giardia has a wide host range and may be 
more accurately described as a species complex comprised of a variety of 
genotypes or assemblages that have different host specificities.2,3  Cysts of 
the various genotypes are morphologically indistinguishable by light 
microscopy and advanced molecular techniques are required to determine 
their assemblage type. A comprehensive phylogenetic study analyzed Giardia 
isolates at 4 different genetic loci, confirming the current distinction of seven 
different lineages.4 Little information exists regarding the differences among 
the various assemblages, with the principal distinction being host range and 
thus zoonotic potential and possibly geographic location. Human infections are 
usually caused by assemblages A and B. Assemblage A is considered to be 
the most important genotype with regards to zoonotic transmission and has a 
wide host range, while assemblage B has a more restricted host range and is 
not commonly isolated from companion animals.  The other 5 assemblages 
appear to be far more host adapted, with assemblages C and D being found 
mainly in dogs, E in livestock, F in cats, and G in rodents. Mixed infections are 
also possible.  
Estimates of prevalence in cats fall within a broad range typically between 1-
10%, in part because infection does not always result in clinical signs and 
diagnostic methods vary greatly.5-23  When clinical signs are present, affected 
cats most commonly exhibit acute small bowel diarrhea with or without weight 
loss. Disease may be severe in a limited number of cases, and large bowel 
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diarrhea, failure to thrive and even vomiting23 have been described in cats 
found to be shedding Giardia cysts in their feces. However, the presence or 
absence of clinical signs is generally not helpful in predicting the infection 
status of a cat; most infections are asymptomatic and in some studies, a 
higher prevalence of intestinal parasitism has been found in cats without 
diarrhea compared to those with diarrhea.10 
Confusion exists regarding the significance of Giardia in cats and the need for 
surveillance and treatment in animal shelters. Data regarding the zoonotic 
potential of Giardia-infected cats is lacking.  Both the host-adapted genotype, 
assemblage F,24-28 as well as the zoonotic genotype, assemblage A,26-30 have 
been found in the populations of cats studied to date. However, insufficient 
data have been collected to allow for determination of the prevalence of and 
risk factors for infection with the different assemblages, and thus a 
quantitative, accurate assessment of the public health risk has not been 
possible. The purpose of this study was to estimate the prevalence of Giardia 
in cats available for adoption at an animal shelter in central New York, assess 
zoonotic risk by determining the assemblage type(s) found in cats shedding 
Giardia cysts, and determine risk factors for infection. 
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Materials and Methods 
Samples and Data Collected 
Once monthly from April 2008-August 2008, a single fecal sample was 
collected from cats and kittens available for adoption at the Tompkins County 
SPCA in Ithaca, New York. This facility is the only shelter serving the rural 
county in which Cornell University is situated, and was an open-admission, 
adoption guarantee organization at the time of the study. The shelter cared for 
approximately 1800 cats during 2008, with approximately 70 to 150 cats 
available for adoption at any given time depending on the month in question.  
All cats 4 weeks of age and older were vaccinated with a modified-live feline 
herpesvirus, calicivirus, panleukopenia vaccine and given a dose of oral 
dewormer (pyrantel pamoate, 10 mg/kg po once). All cats were fed a standard 
commercially available dry diet as appropriate for their age (Science Diet® 
Adult Cat Original or Science Diet® Kitten Healthy Development Original, 
Hill’s® Pet Nutrition, Topeka, KS). Cats available for adoption were 
predominantly group housed in small rooms with several other cats (Figure 1).  
Room sizes ranged from 16.5 to 170 square feet with 1-18 cats per room.  
Some cats were housed individually in small rooms or cages as necessary for 
management of medical conditions (e.g. feline lower urinary tract disease) 
and/or behavioral reasons (Figure 1). 
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Figure 1: Representative examples of group and individual housing of cats 
available for adoption at the Tompkins County SPCA. Rooms range in size 
from 16.5 ft2 to 75 ft2. 
A: Smaller room for group housing (32.5 ft2) 
B: Larger room for group housing (70 ft2) 
C: Individual housing in cages 
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Each cat was individually examined by one of two of the authors within 3 days 
of sample collection in order to determine age, sex, body weight, and body 
condition score. Cats were assigned a body condition score on a scale of 1 to 
9 according to a standardized scoring chart (Purina body condition score 
chart; Nestle Purina, St. Louis, MO). The following information was collected 
from the shelter records for each cat, if available: date of entry to the shelter, 
body weight at time of entry, origin (stray vs. owner surrendered), and outdoor 
access of surrendered cats (indoor only, predominantly outdoor, or 
indoor/outdoor).  The following information was recorded at the time of sample 
collection for each cat: date of sample collection, type of housing (individual 
vs. group), number of other cats in the housing unit (if applicable), housing unit 
dimensions, and total number of cats in the shelter.  The length of stay in the 
shelter (as determined from the date of entry and the date of sample 
collection), change in body weight (as determined from the weight at time of 
entry and weight at time of sampling), square footage per cat (as determined 
from the housing unit dimensions and number of other cats in the housing unit, 
if applicable) were calculated for each cat. 
An attempt was made to collect a sample from every cat housed in the 
adoption area over seven days’ time during the same week every month; 
samples were successfully collected from all but approximately 4-10% of cats 
depending on the month. Some cats were missed because they were removed 
from the adoption area or because there were an insufficient number of fecal 
markers available to obtain an individually identifiable sample from each cat 
housed in larger groups. Samples were collected from cats housed in cages 
and in colony rooms. In addition to their usual dry food, cats were also offered 
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canned cat food (Science Diet® Adult Optimal CareTM Liver & Chicken Entrée, 
Hill’s® Pet Nutrition, Topeka, KS). Group-housed cats consumed food coloring 
or glitter once daily in their canned food during the sample collection period 
according to the methods of Griffin.31 These served as fecal markers, allowing 
identification of each cat’s feces (Figure 2). All feces were collected from the 
litter boxes prior to cleaning in the morning for all cats. For group housed cats, 
fecal samples were individually inspected by two of the authors or trained 
observers for the presence of a fecal marker.  A sample was identified for 
each cat and scored using a standardized fecal scoring system (Fecal Scoring 
System, Ralston Purina, St. Louis, MO).  Data were collected on a 
standardized collection form. 
Samples were stored at 4°C and tested within 5 days of collection for the 
presence of Giardia antigen using a commercially available ELISA test 
(SNAP® Giardia Test, IDEXX Laboratories, Westbrook, ME) in accordance 
with the manufacturer’s instructions. A sample was considered positive if any 
intensity of color was visible on the Giardia sample spot; if a result was in 
doubt (e.g. very faint color change), the sample was considered positive to 
minimize any chance of artificially lowering the prevalence and 
underestimating the public health risk. Giardia infection was defined by at least 
one positive ELISA result and a positive cat was considered a case. Any cat 
that did not test positive served as a control.  Cats that were in the adoption 
area for multiple months during the study were sampled multiple times. This 
study was reviewed and approved by the Cornell University Institutional 
Animal Care and Use Committee. 
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Figure 2: Food coloring and glitter were used as fecal markers for cats that 
were group housed, allowing identification of each cat’s feces.                         
A: Fecal markers were mixed with a commercially available canned 
food and offered to cats 
B: Most cats readily consumed the colored canned food 
C: Fecal markers consistently produced distinctive coloration of feces 
allowing for easy identification by trained observers. Clockwise from the 
upper left, individually bagged pink, red, teal, and black samples are 
seen in bags with cat litter. 
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Fecal Flotation and Cyst Concentration 
Any fecal sample with a positive result on the ELISA test was processed for 
genotype analysis.  Magnesium sulfate centrifugation-flotation was performed 
to concentrate the cysts, and samples were examined by light microscopy to 
estimate the number of Giardia cysts per gram of feces.  In brief, 5 g of feces 
were mixed with distilled water, strained using cheese cloth, and allowed to 
settle at 4°C for up to 90 minutes. The sediment was then centrifuged at 
1200g for 5 minutes. The resulting pellet was then resuspended with 
magnesium sulfate flotation solution (specific gravity 1.30) and centrifuged at 
1200g for 5 minutes. The top 15 mL of supernatant was filtered through 25 
and 75 micron mesh filters, and the resulting filtrate was mixed with water to a 
specific gravity of 1.0 and allowed to settle for at least one hour at 4°C. The 
supernatant was removed and the remaining 50 mL was centrifuged at 1200g 
for 5 minutes. The supernatant was again removed, leaving a 5 mL pellet that 
was washed with half-strength phosphate buffered saline solution. The 
remaining solution was centrifuged at 800g for 5 minutes, the supernatant was 
decanted, and the pellet was resuspended in 1mL of remaining supernatant.  
Samples were stored at 4°C and shipped overnight on ice for molecular 
analysis at the Agricultural Research Service, United States Department of 
Agriculture, Beltsville, MD. 
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PCR and Sequencing Analysis 
At the Agricultural Research Service, DNA was extracted from 50 μl of the 
concentrated cyst suspension, using a DNeasyTissue Kit (Qiagen, Valencia, 
CA). To maximize recovery of DNA, the nucleic acid was eluted in 100 ml of 
AE buffer (elution buffer included in DNeasyTissue Kit). For Giardia, a 
fragment of the SSU-rDNA (~292 bp) gene was amplified by PCR as 
previously described.24,32 For the primary PCR step, the PCR mixture 
contained 1x PCR buffer, 1.5mM MgCl2, 0.2mM each dNTP, 2 U Taq, 2.5 μl of 
dimethyl sulfoxide (DMSO), and 0.5mM for each forward and reverse primer in 
a total of 50 μl reaction volume. A total of 35 cycles, each consisting of 96 ºC 
for 45 s, 58 ºC for 30 s, and 72 ºC for 45 s, were performed; an initial hot start 
at 96 ºC for 2 min and a final extension step at 72 ºC for 4 min were also 
included. For the secondary PCR step, the PCR mixture was identical. A total 
of 35 cycles, each consisting of 96 ºC for 45 s, 58 ºC for 30 s, and 72 ºC for 45 
s, were performed; an initial hot start at 96 ºC for 2 min and a final extension 
step at 72 ºC for 4 min were also included. PCR products were analyzed on 
1% agarose gel and visualized by ethidium bromide staining. Exonuclease 
I/shrimp alkaline phosphatase (Exo-SAP-IT,® USB Corporation, Cleveland, 
OH) was used to purify the PCR products that were then sequenced using the 
same PCR primers in 10 μl reactions with Big DyeTM chemistries and an 
ABI3100 sequencer analyzer (Applied Biosystems, Foster City, CA). After 
each specimen was sequenced in both directions, chromatograms from each 
strand were aligned and inspected using Lasergene software (DNASTAR Inc., 
Madison, WI). 
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Data and Risk Factor Analysis 
Information collected was entered into a spreadsheet and imported into a 
commercially available software package for statistical analysis (Statistix 9.0, 
Analytical Software, Tallahassee, FL). Monthly prevalence of Giardia infection 
was calculated by dividing the number of cats that tested positive on the 
ELISA by the number of individual cats sampled monthly. The prevalence of 
infected cats for the 5 month period of the study was estimated by dividing the 
number of cats that tested positive at least once by the number of cats 
sampled at least once. Prevalence was expressed as a percentage and 95% 
confidence intervals were calculated.   
Associations between infection status (or assemblage type) and the following 
variables were evaluated: age, age group (adults > 6 months of age, kittens ≤ 
6 months of age), sex, body weight, body condition score, change in body 
weight since entry to the shelter, origin (stray vs. owner surrender), outdoor 
access (when provided for owner surrendered cats; any vs. none), season of 
entry (January – March, April – June, July – September, October – 
December), length of stay in the shelter, type of housing (individual vs. group), 
number of other cats in the housing unit, number of cats in the shelter, square 
footage per cat in the housing unit, number of fecal samples collected, and 
fecal score. 
Associations between potential risk factors and Giardia infection status and 
assemblage type were first evaluated in a univariate analysis (i.e. one factor at 
a time). In the analyses of factors associated with Giardia infection, the 
characteristics of infected cats were evaluated at the time of the first positive 
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sample. Since controls may also have been sampled more than once, 
characteristics from one randomly selected sampling were recorded for each 
control cat. Therefore, every cat was represented only once in the assessment 
of risk factors for Giardia infection. In the analyses of factors associated with 
assemblages, the assemblage types were first categorized into those that may 
be zoonotic (assemblages A and B) and those that are thought not to be 
zoonotic (assemblage F). Since more than one assemblage could be 
recovered over time in a cat and characteristics (e.g. weight, number of cats in 
housing enclosure) could changed with time, factors associated with zoonotic 
vs. non-zoonotic types were evaluated with the sample (rather than cat) as the 
unit of analysis. 
The association between categorical variables (e.g. gender, origin) and 
Giardia infection (or assemblage type) status was assessed using the chi-
square test of independence or Fisher’s exact test (where expected cell values 
were less than 5). Differences of continuous factors (e.g. age, body weight) 
between groups (Giardia positive and negative or potentially zoonotic and 
host-adapted) were evaluated using the Student t test (for Normally distributed 
data) or the Wilcoxon rank sum test (for non-Normally distributed data). 
Variables with p values < 0.20 were examined further as risk factors for 
Giardia infection using unconditional logistic regression to examine the joint 
effect of these factors and to control for confounding. Variables with p values < 
0.25 were examined further as risk factors for infection with a particular 
assemblage with unconditional logistic regression. The model parameters for 
associations with infection status or assemblage type were obtained by 
maximum likelihood estimation using the computer program (EGRET® version 
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2.0.3 for Windows, Cytel Inc., Cambridge, MA).  The models were constructed 
using a forward stepwise approach, and significance was determined by 
evaluating the likelihood ratio chi-square statistic in each step of the fitting 
process. Variables significant at p ≤ 0.05 were retained in the final model. The 
regression coefficients were exponentiated to obtain adjusted odds ratios, and 
95% confidence intervals were calculated. 
 
Results 
Prevalence of Giardia Infection 
During the 5 month study period, a total of 554 fecal samples were collected 
from 302 different cats, and 61 ELISA positive samples were obtained from 49 
different cats. The overall prevalence of Giardia-positive cats from April-
August was 16.2% (49/302); 95% CI: 12.3% - 21.0%. The monthly prevalence 
ranged from 6.6% to 14.8% (Figure 3 and Table 1), and the number of cats in 
adoption increased by approximately 20 cats per month over the study           
(p = 0.0004). The prevalence was significantly (p = 0.03) higher in the summer 
(June, July, August) compared to spring (April, May) months.  
The number of samples obtained from positive cats was significantly (p = 0.01) 
higher (median 2.2, range 1-5) than among control cats (median 1.7, range 1-
5).  Giardia positive cats had a significantly higher proportion of males than 
controls (p = 0.05), and were significantly younger compared to cats testing 
negative (p = 0.12). Although the median age for both cases and controls was 
1.5 years, there was still significant variation between the two groups because 
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of differences in the distribution.  Positive animals were also more likely         
(p = 0.20) to have been strays (60%) compared to negative cats (50%) and if 
owner-surrendered to have had outdoor access (p = 0.10) (Table 2). 
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Figure 3: Monthly prevalence of Giardia infection and average number of cats 
in the adoption area of the shelter at the time of sampling. 
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Table 2: Host characteristics and potential risk factors for Giardia infection in 
cats in an animal shelter in New York state. 
 
 
 
Variable 
 
 
Description 
 
Cases 
 
Controls 
 
p value
Age (years) Median 1.5 1.5  
 Range 0.2-8.0 0.1-13.0 0.12 
Body condition score Median 5.0 5.0  
 Range 4.0-9.0 3.0-9.0 NS 
Body weight Median 3.4 3.5  
at intake (kg) Range 0.4-8.9 0.3-9.0 NS 
Body weight at Median 3.3 3.5  
sample collection (kg) Range 0.9-9.1 0.7-8.8 NS 
Number of fecal  Median 2.2 1.7  
samples collected Range 1-5 1-5 0.01 
Length of stay (days) Median 54 48  
 Range 3-264 1-383 NS 
Total # cats in shelter Median 370 427  
 Range 165 - 448 168-448 NS 
Total # cats  Median 113 135  
in adoption Range 78-162 78-162 NS 
# cats in housing unit Median 6 4  
 Range 1-17 1-18 0.10 
Sq. footage per cat Median 5.7 6.3  
 Range 3.0-56.7 3.0-170.0 NS 
   Cases 
 
Controls 
 
 
 
Variable 
 
Description 
 
 
No. 
 
% 
 
No. 
 
% 
 
p value
Sex Female 20 40.8 137 56.4  
 Male 29 59.2 106 43.6 0.05 
Origin Surrendered 21 40.0 126 50.0  
 Stray 30 60.0 121 50.0 0.20 
Outdoor access Yes 4 80.0 12 40.0  
 No 1 20.0 18 60.0 0.10 
Housing in shelter Individual 4 7.8 44 17.7  
 Group 47 92.2 204 82.3 NS 
Weight loss Any 7 15.9 72 36.9  
 None 37 84.1 123 63.1 0.007 
 
NS – not significant 
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Potential Risk Factors for Giardia Infection in All Cats  
More than 80% of all cats sampled were housed with other cats (range 1 – 17 
other cats).  Giardia positive cats were housed with a greater number of cats 
(p = 0.08) than negative cats. Although body weight at the time of intake and 
time of sampling and body condition score were not associated with Giardia 
status, uninfected cats were nearly twice as likely to have lost weight during 
their stay in the shelter than Giardia positive cats (p = 0.007). The length of 
stay in the shelter, total number of cats in the adoption area, square footage 
per cat, and type of housing (individual vs. group) did not differ significantly 
between Giardia positive and Giardia negative cats.   
 
Potential Risk Factors for Giardia Infection by Age Group  
Since risk factors differed by age group at the time of sampling, data were also 
analyzed separately for adult cats and kittens (Table 3).   
 
Adult cats: Among adult cats greater than 6 months of age, Giardia-positive 
cats were significantly younger than controls (p = 0.08). Similarly, adult male 
cats were overrepresented among positive cats (52.9% among cases and 
38.5% among controls) (p = 0.11). 
 
Giardia positive adults were more likely to have been found as strays (75.8%) 
than Giardia negative cats (52.8%) (p = 0.05). Information regarding outdoor 
access was available for a small number (n = 35) of adult, owner-surrendered 
cats; 80% (4/5) of Giardia positive cats had outdoor access compared to only 
40% (12/30) of control cases (p = 0.10). 
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Table 3: Host characteristics and potential risk factors for Giardia infection in 
adult cats in an animal shelter in New York state 
 
 
 
Variable 
 
 
Description 
 
Cases 
 
Controls 
 
p value
Age (years) Median 2.0 2.5  
 Range 0.2 – 8.0 0.2 – 13.0 0.08 
Body condition score Median 6.0 6.0  
 Range 4.0 – 9.0 3.0 – 9.0 NS 
Body weight Median 4.1 4.0  
at intake (kg) Range 0.7 – 8.9 0.3 – 9.0 NS 
Body weight at Median 5.0 4.2  
sample collection (kg) Range 1.1 – 9.1 1.1 – 8.8 0.16 
Number of fecal  Median 3.0 1.0  
Samples collected Range 1.0 – 5.0 1.0 – 5.0 0.004 
Length of stay (days) Median 58 60  
 Range 4 – 264 1 – 383 NS 
Total # cats in shelter Median 335 341  
 Range 165 – 448 168 – 448 NS 
Total # cats Median 113 113  
in adoption Range 78 – 162  78 – 162  NS 
# cats in housing unit Median 6 4  
 Range 1 – 17 1 – 18 0.02 
Sq. footage per cat Median 5.9 7.0  
 Range 3.4 – 56.7 3.0 – 170.0 NS 
   Cases 
 
Controls 
 
 
 
Variable 
 
Description 
 
 
No. 
 
% 
 
No. 
 
% 
 
p value
Sex Female 16 47.1 112 61.5  
 Male 18 52.9 70 38.5 0.11 
Origin Surrendered 8 24.2 84 47.2  
 Stray 25 75.8 94 52.8 0.05 
Outdoor access Yes 4 80 12 40  
 No 1 20 18 60 0.10 
Housing in shelter Individual 3 8.8 40 21.7  
 Group 31 91.2 144 82.3 0.08 
NS – not significant 
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 Among adult cats, there was also a significant association between Giardia 
cyst shedding and being housed with a greater number of cats (p = 0.02).  
Control cats were housed in groups with a median size of 4 cats compared to 
groups with a median size of 6 cats for cases.  Infection status was associated 
with group housing in that 91.2% (31/34) of Giardia positive cats were group 
housed compared to 78.3% (144/184) of Giardia negative adults (p = 0.08).  
Kittens: When data for kittens 6 months of age and younger were analyzed, 
none of the previously mentioned associations were statistically significant.  
Mean body weight at the time of sample collection was greater for Giardia 
positive kittens than for controls, with control kittens having a median weight of 
1.4 kilograms compared to 1.8 kilograms (p = 0. 023) among infected kittens. 
Weight change was also associated with infection status; no infected kittens 
lost weight during their time at the shelter (0/15) compared to 16.4% (51/61) of 
control kittens (p = 0.09). However, there was no difference in body condition 
scores between infected and uninfected kittens.  
Multivariate analysis:  For adults, age and origin (e.g. owner surrendered or 
stray) were found to be significant risk factors for Giardia infection in the 
multivariate model (Table 4). The odds ratio decreased by approximately 18% 
for each 1 year increase in age. Stray cats were 2.69 times more likely to be 
infected than owner-surrendered cats. For kittens, body weight at the time of 
sample collection was the only factor found to be significant in the regression 
analysis. An increase of 1 pound in body weight at the time of sample 
collection increased the odds of being positive on the SNAP® Giardia test by 
72% (OR 1.72; 95% CI 1.02-2.78).   
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Table 4. Multivariate (logistic regression) models of risk factors associated 
with Giardia infection among cats available for adoption at an animal shelter. 
 
 
 
Model I: Giardia infection in Adult Cats  
 
 
Risk Factor: 
 
 Age 
 
 Origin 
             Owner-surrendered 
             Stray 
 
 
Odds Ratio 
 
0.82 
 
 
1.00 
2.66 
 
 
95% CI 
 
0.66 – 1.04 
 
 
 
1.14 – 6.34 
 
 
 
 
 
 
Prevalence of Assemblage Types 
Prevalence: A total of 61 fecal samples that tested ELISA positive for Giardia 
were submitted for molecular analysis, and assemblage type was determined 
for 72% (44/61) of the samples.  Those samples for which an assemblage type 
could not be identified (i.e. PCR negative) were excluded from the analysis.  
Because of the small sample size, the assemblage types were collapsed into 
two categories for the purpose of analysis: those characterized as potentially 
zoonotic and those that are not zoonotic. Both zoonotic and host-adapted 
assemblages were identified (Table 5); 75% (33/44) of the PCR positive 
samples were the host-adapted assemblage F, while 25% (11/44) of samples 
had zoonotic potential based on reported host ranges (assemblages A, B, and 
mixed A/F infections). Cyst counts did not differ significantly among cats 
 46
identified as having potentially zoonotic, host-adapted, or PCR negative 
assemblage results.  Demographic information is presented for all cats on the 
basis on infection type (e.g. potentially zoonotic or host-adapted assemblages) 
in Table 5. 
 
 
 
 
 
Table 5. Giardia assemblage types found in ELISA positive fecal samples 
collected from cats available for adoption at an animal shelter. 
 
Assemblage 
type 
Reported host range2 Number 
identified 
Zoonotic 
potential? 
PCR 
negative 
 
N/A 
17 
 (27.9%) 
 
N/A 
 
A 
Humans, livestock, cats, dogs, 
beavers, guinea pig, slow loris 
2  
(3.3%) 
 
Yes 
 
B 
Humans, slow loris, chinchillas, 
dogs, beavers, rats, siamang 
6  
(9.8%) 
 
Yes 
 
F 
 
Cats 
33  
(54.1%) 
 
No 
 
Mixed A & F 
 
N/A 
3  
(4.9%) 
 
Yes 
 
N/A not applicable 
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Table 6: Host characteristics and potential risk factors for assemblage type 
among Giardia infected cats in an animal shelter in New York state 
 
 
 
 
 
Variable 
 
 
 
 
Description
 
Assemblage
A, B or 
mixed 
 
Assemblage 
F 
 
p value 
Age (years) Median 1.5 1.5  
 Range 0.4-3.0 0.2-6.0 NS 
Body condition   Median 6.0 5.0  
Score Range 5.0-9.0 4.0-7.0 0.16 
Body weight Median 4.3 3.3  
At intake (kg) Range 0.7-8.9 0.6-6.7 0.11 
Body weight at  Median 4.4 3.5  
sampling (kg) Range 2.0-9.1 0.9-6.4 0.14 
Days in shelter Median 46 66.5  
 Range 12-119 3-264 NS 
Total # cats in  Median 435 399  
Shelter Range 245-448 165-448 NS 
Total # cats in Median 135 124  
Adoption Range 97-162  78-162 NS 
# cats in housing 
unit 
Median 6.5 5.0  
 Range 1-18 1-18 NS 
Sq. footage per 
cat 
Median 5.9 5.7  
 Range 3.9-12.2 3.0-56.7 NS 
   Assemblage
A, B or 
mixed 
 
Assemblage 
F 
 
 
 
Variable 
 
Description
 
 
No. 
 
% 
 
No. 
 
% 
 
p value 
Sex Male 7 63.6 18 54.5  
 Female 4 36.4 15 45.5 NS 
Origin Surrender 3 30.0 11 32.4  
 Stray 7 70.0 23 67.6 NS 
Outdoor access Yes 1 100 4 80.0  
 No 0 0 1 20.0 NS 
Housing in shelter Individual 1 10.0 1 2.9  
 Group 9 90.0 33 97.1 NS 
Age group Kitten 1 8.3 11 91.7  
 Adult 10 31.2 22 68.8 0.24 
NS – not significant 
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Potential Risk Factors for Zoonotic Assemblage Types 
Univariate analysis: Most infections were not of zoonotic potential, but adults 
were more frequently infected with potentially zoonotic assemblages (p = 0.24) 
than kittens were. More than 90% of samples obtained from kittens were 
assemblage F (11/12 samples) compared to approximately 69% of samples 
obtained from adults. There was a striking seasonal trend with regards to 
assemblage type. Every cat infected with a potentially zoonotic genotype 
entered the shelter between the months of April and June, compared to only 
64.7% of cats infected with assemblage F (p = 0.04).   
Cats with potentially zoonotic assemblages were significantly more likely to 
have higher fecal scores (e.g. soft stools or diarrhea) than those cats infected 
with the host-adapted genotype (p = 0.03). For cats with potentially zoonotic 
assemblages, 40% (4/10) had soft stools and 20% (2/10) had diarrhea. For 
cats with assemblage F, 28% (9/32) had soft stools and 3% (1/31) had 
diarrhea. Other gastrointestinal parasites (Isospora spp. n =20, Toxocara spp. 
n = 4, Aelurostrongylus spp. n =1, Ancylostoma spp. n =1) were identified in 
39% (24/61) of SNAP® positive fecal samples.  Cats with potentially zoonotic 
assemblages were just as likely (3/11) to be co-infected with other parasites 
as cats with assemblage F (12/33) (p = 0.58).   
Cats infected with potentially zoonotic assemblages tended to be of higher 
body weight both at entry to the shelter (p = 0.14) and at the time of sample 
collection (p = 0.11) than those with assemblage F, likely due to confounding 
by age (e.g. adults and older kittens weighed more than younger kittens).  
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Cats with potentially zoonotic assemblages also had higher body condition 
scores (p = 0.16) than those cats infected with the host-adapted isolates. 
Among adult cats, there was no difference between body weight at time of 
entry to the shelter or at the time of sample collection or with body condition 
score between cats infected with the different assemblages.  Cats infected 
with potentially zoonotic strains had been in the shelter for a significantly (p = 
0.04) shorter period of time (median 44 days) than those cats infected with the 
host-adapted assemblage F (median 78 days).  When data for kittens were 
analyzed, none of the previously mentioned associations were statistically 
significant.   
Multivariate analysis:  Since too few kittens were infected potentially zoonotic 
assemblages, multivariate modeling was not attempted and risk factor analysis 
was performed using logistic regression for adults only. Among adult cats, 
higher fecal scores (e.g. soft stools, diarrhea) were a significant risk factor for 
infection with a potentially zoonotic assemblage. For each 1 unit increase in 
fecal score, the odds of being infected with a potentially zoonotic assemblage 
increased by a factor of 1.96 (95% CI: 1.00 – 3.85) compared to the odds of 
being infected with the host-adapted assemblage F. 
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Discussion 
The overall prevalence of Giardia-positive cats from April-August was 16.2%, 
which is within the range or slightly higher than that reported in other 
studies.5,6,9-12,14-22,27 Investigators have failed to consistently find a higher 
prevalence of Giardia in shelter cats compared to owned cats, but it is 
generally accepted that prevalence rates are higher in group-housed 
animals.1,13,33  It has been hypothesized that cats housed in animal shelters 
are at greater risk of infection because of increased direct contact with other 
cats and their feces, the immunosuppressive effects of stress, and contact 
with a potentially contaminated environment.11,12  Because most of the cats 
available for adoption in this shelter were group housed, their exposure to 
other cats and their feces was probably higher than for cats in animal shelters 
with traditional individual housing.  Although previous studies involving cats 
from animal shelters did not specify the type of housing, it is possible that the 
relatively high prevalence reported in this study is due to group housing rather 
than being in a shelter setting per se.  Although neither association was 
significant (p = 0.10) in the final multivariate model, a higher proportion of 
Giardia positive cats were group housed than controls and they were housed 
with a greater number of cats.  The lack of significance may be due to a lack of 
statistical power rather than an absence of association as less than 20% of 
cats in the adoption areas of this shelter were housed in individual cages.   
There was a significant association for adult cats between Giardia cyst 
shedding and being housed with a greater number of cats in the univariate 
analysis, but this factor was not retained in the final multivariate model.  
Control cats were in smaller groups (median size 4 cats) than infected cats 
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(median size 6 cats), suggesting that an undetermined factor associated with 
group size may increase the risk of being infected with Giardia. However, it is 
not possible to use this data to determine a specific number of cats above 
which a housing unit is too crowded or the rate of contact becomes too high. 
The success of group housing depends greatly on the space and quality of the 
environment as well as its management, including the provision of an 
adequate number of litter boxes and diligent maintenance. Group housing is 
not appropriate for all cats (e.g. “bully” cats) and ideally cats should be 
introduced slowly to minimize stress and disruption of the social structure. 
Because of these many factors, the point at which an area becomes 
overcrowded is dependent on specific circumstances.  Although colony 
housing itself was not significantly associated with infection, this may also be 
due to low power to detect a difference as only 8.8% of Giardia infected cats 
were individually housed.  
The higher prevalence in this shelter in summer months is not surprising 
because of the high numbers of cats and kittens entering the shelter at that 
time of year. The amount of space available for each cat housed in a group 
was reduced as the number of cats housed in the shelter increased each 
month (Table 1).  One might expect to find a consistent linear trend between 
the number of infected cats and the total number of cats in the shelter or the 
square footage per cat.  However, neither square footage per cat nor the total 
number of cats in the shelter or the adoption areas were correlated 
significantly with continually increasing prevalence (Figure 3). This may have 
been the result of on-going removal of infected cats from the population for 
treatment. According to the shelter’s policy, positive cats were isolated in a 
 52
separate area of the shelter and treated with metronidazole (25 mg/kg po q12 
hours for 5 days) and fenbendazole (50 mg/kg po q24 hours for 5 days). 
These cats were not returned to the general population until treatment had 
been deemed successful on the basis of fecal flotation.  Removal of the 
infected cats from the adoption population would have reduced the spread of 
disease that may have occurred had these cats not been identified and/or 
remained within the population, particularly given the group housing structure.  
Other factors that may be responsible for the discrepancy in overall 
prevalence between this and other studies include geographic location, study 
population (e.g. healthy cats awaiting adoption in an animal shelter), and 
differing diagnostic methods. However, the prevalence reported here may still 
be an underestimate of the true prevalence on Giardia infection in cats in this 
shelter.  Because cysts are shed intermittently, it is possible that some cats 
were incorrectly identified as being uninfected on the basis of a single fecal 
sample.  The ZnSO4 centrifugation-flotation technique (ZNCT) has been 
considered the gold standard for the diagnosis of Giardia when used by 
trained personnel, but at least three ZNCTs performed on consecutive fecal 
samples must be negative in order to rule out Giardia infection.1,34-36  
However, ELISA and IFA evaluations are increasing in use and acceptance. 
Because the ELISA tests detect an antigen produced by the trophozoites that 
is shed continuously, they theoretically avoid the problems of intermittent cyst 
shedding and the need for multiple fecal samples. Thus, their use may result 
in comparable prevalence estimates to those obtained using multiple ZNCTs. 
The sensitivity and specificity of the SNAP® Giardia Test range from 90-95% 
and 96-100% respectively, and independent studies have shown that these 
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tests have high sensitivities and specificities when used in cats.1,20,37  For 
these reasons, and because collection of multiple fecal samples from 
individual cats was neither technically nor economically feasible in this study, 
diagnosis was based on a positive ELISA result in a single sample using an in-
house kit.  It would be possible to correct the apparent prevalence estimates to 
true prevalence estimates using the sensitivity and specificity of the ELISA; 
because these are so high, the apparent prevalence would change a nominal 
amount and such calculations were not done in this study.  
Although many cases were tested only once and many controls were tested 
every month during the study period, A higher median number of fecal 
samples were collected from Giardia positive cats than from controls.  This 
may have biased the estimates upwards because of the enhanced sensitivity 
gained from testing multiple samples. Nonetheless, diagnosis may have been 
improved by using a more sensitive screening test than the ELISA.  For 
instance, one study found a 0% prevalence of Giardia using fecal flotation and 
microscopic evaluation,11 but an 80% prevalence using PCR on the same 
samples.12 These results, while limited, suggest that false negatives are 
unlikely to occur with PCR.  Although false positives are possible with such 
screening techniques, PCR analysis of all fecal samples may have increased 
sensitivity and would have allowed for the determination of assemblage type 
for those cats falsely testing negative with the SNAP® Giardia Test.  
Insufficient data exists to conclusively determine whether the ELISA tests in 
general, and the SNAP® Giardia Test in particular, are able to detect all 
genotypes of Giardia duodenalis with equal sensitivity and specificity. 
Moreover, it is possible but unknown whether there is an association between 
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assemblage type and intensity of cyst shedding, although we were unable to 
find any association between PCR results and cyst counts in this study.  
However, it is possible that PCR may be able to detect Giardia in samples with 
antigen levels below the detection threshold of the in-house ELISA kits.  
Risk Factors: Cats greater than 6 months of age and those 6 months old or 
younger had different risk factors associated with testing positive for Giardia in 
this study. Although few risk factors were identified for kittens, several risk 
factors for infection in adult cats were identified that are unique to cats in 
animal shelters and may also pertain to cats in other group-housing settings 
such as catteries. Unfortunately, despite having more than 500 fecal samples 
from 302 different cats, the low number of infected cats and kittens greatly 
reduced the power to find risk factors for infection.  We failed to find a higher 
rate of infection in kittens less than 6 months of age compared to older cats. 
Because kittens are considered highly desirable by the general public, they 
tend to spend only a short period of time in the shelter before adoption unless 
they are too young to be available for immediate adoption (e.g. less than 8 
weeks of age). As a result, the majority of cats sampled during the study 
period were greater than 6 months of age. Only mean body weight at the time 
of sample collection was greater for Giardia positive kittens than for controls, 
suggesting that these kittens had been in the shelter for a longer period of time 
than those that were uninfected and/or were older when they entered the 
shelter. 
The larger number of adult cats sampled allowed for a better assessment of 
potential risk factors for infection.  Giardia positive adults were more likely to 
have been found as strays (75.8%) with an odds ratio of 2.41 for stray cats 
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compared to owner-surrendered cats. Information regarding outdoor access 
was available for a small number (n = 35) of adult, owner-surrendered cats. 
Because of this small sample size, there was low power to detect a significant 
difference, but 80% (4/5) of Giardia positive cats had outdoor access 
compared to only 40% (12/30) of control cases. This is not surprising, given 
that stray cats and those with outdoor access are likely to be at greater risk of 
exposure to parasitic and infectious diseases.  
There was a trend for Giardia positive cats to be younger than controls; 
although not statistically significant in this study overall, infected adult cats 
were significantly younger than adult controls. Younger animals have been 
reported to be at higher risk of Giardia infection in other studies and this is 
biologically plausible given the naïve immune system of young animals.6,7,15,21  
Alternatively, it has been suggested that older cats may become refractory to 
Giardia infection because of acquired immunity.11,12  Among adults, the odds 
of being Giardia positive decreased by approximately 27% with each 
increasing year of age. In other words, increasing age was associated with 
decreasing risk of Giardia infection.  Although there was a tendency for males 
to be underrepresented among control cats, this factor was not retained in the 
final model.   
A sex predilection has not been previously reported in humans or animals, and 
current understanding of the epidemiology and pathophysiology of Giardia 
infection does not suggest a basis for such a predisposition. It is likely that this 
trend is spurious. 
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Assemblage data: Both potentially zoonotic and non-zoonotic assemblages 
were detected in the fecal samples of cats in this animal shelter.  Although 
cats are well-recognized to be susceptible to infection with assemblages A and 
F, to the authors’ knowledge, this is only the second report of the detection of 
assemblage B in cats. Interestingly, the only previous report of assemblage B 
was also from cats sampled in the same geographic region as the present 
study.29 In that study, 3 of 9 cats sampled were identified with assemblage B 
while the other 6 cats were identified as being infected with assemblage A. 
However, demographic information for the cats in the previous study was not 
presented, and thus no assessment of differences in assemblage type could 
be made.  Some investigations have found the study population to be 
exclusively infected with assemblage A30 or assemblage F,24,25 while other 
studies have found the population of cats in question to be infected with both 
assemblages A and F alone or in combination (e.g. mixed infections.) 26-28  
Rarely, infection with other “host-adapted” assemblages (e.g. assemblages C 
and D) has been reported in cats.12 Despite a growing body of scientific 
literature, little data exists regarding differences in assemblage types other 
than host specificity and possible geographic distribution.2,3  Although 
assemblages A and B have a wide host range (including humans), this only 
suggests a potential for zoonotic spread, but neither guarantees its occurrence 
nor specifies the direction of transmission if it occurs.    
While not statistically significant, adults were more likely than kittens to be 
infected with potentially zoonotic assemblages.  More than 90% (11/12) of 
samples obtained from kittens were assemblage F.  Although it was not 
specifically investigated, it seems likely that cats who become infected with 
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Giardia while in the shelter are more likely to be infected with the host-adapted 
assemblage F. This is supported by the fact that more than 80% (18/22) of 
cats that tested positive after being in the shelter 60 days or longer were 
infected with assemblage F. On average, these 18 cats had tested negative on 
two occasions (range 0-4 previous tests) prior to the point at which infection 
with assemblage F was detected.  Given the target (e.g. cyst wall antigen) of 
the ELISA tests and their high sensitivities, it is improbable that these cats 
would have had multiple false negative results on the earlier tests. Screening 
at the time of entry to the shelter would have been necessary to definitively 
establish that cats were not infected at the time of arrival but acquired the 
infection in the shelter; unfortunately this was not possible in this study. 
Interestingly, all cats infected with a zoonotic assemblage entered the shelter 
between the months of April and June.  It was not possible to determine if all 
of these cats came from a common location that would suggest a point source 
exposure, but intake dates varied by as much as 3 months within this time 
frame making such exposure very unlikely. It may be that cats were more 
likely to come in contact with assemblage A and B Giardia isolates during the 
months preceding their entry (e.g. February and March) to the shelter, perhaps 
as a result of environmental factors that are more conducive to transmission of 
Giardia in these months. With seasonal rain and snow melt, the cool and moist 
environment favors the persistence of cysts1. Unfortunately, it was not 
possible in this study to collect data throughout the entire year to better assess 
any possible influence of season on Giardia infection.      
For cats greater than 6 months of age, higher fecal scores (e.g. soft stools or 
diarrhea) were a significant risk factor for infection with a potentially zoonotic 
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assemblage. Due to the small sample size, there was insufficient power to 
detect a significant difference between fecal scores when they were collapsed 
into more intuitive categories of “normal” or “diarrhea” but the highly significant 
association with the ordinal variable of fecal score suggests that the risk of 
infection with a potentially zoonotic strain is greater for cats with soft stools or 
diarrhea. The presence and severity of clinical signs associated with infection 
are determined by many host and parasite factors. We were unable to find an 
association between potentially zoonotic assemblages and concurrent 
parasitism, suggesting that parasite genotype may be an important 
determinant of the severity of disease. It is known that infection with different 
assemblages can cause varying clinical signs in humans,39,40 but this has not 
been investigated in cats. However, it is reasonable to expect that the host 
adapted assemblages would not cause as severe clinical disease and the 
results of this study support that hypothesis.  
Interestingly, cats infected with potentially zoonotic strains had been in the 
shelter for a significantly shorter period of time than those cats infected with 
the host-adapted assemblage F. Although this factor was not retained in the 
final multivariate model, it raises the question or immunity to and persistence 
of Giardia infection in cats and warrants further study.  It is unknown whether 
infection with one assemblage imparts cross protection against infection with 
other assemblages or if the immunity is genotype-specific, and no data exist 
for cats regarding the persistence of infection with respect to assemblage type.  
Recent studies have found that dogs in household settings are equally likely to 
be infected with assemblage A as their own host-adapted assemblages C and 
D,41 but are predominantly infected with the host-adapted genotypes in areas 
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that are highly endemic among animals for Giardia.32  As a result of these 
findings, it has been suggested that competitive exclusion occurs in dogs in 
environments with high infection pressure, whereby the host-adapted 
assemblages “out-compete” the other assemblages.28 It is unknown if this 
occurs in cats.   
Some cats in this study that were sampled multiple times tested positive for 
Giardia on more than one occasion (n = 7). In these cats, the same 
assemblage type may or may not have been found in subsequent samples.  
One cat was initially infected with assemblage A and then found to be infected 
with assemblage B one month later. Two cats were found to be infected with 
assemblage F on two separate occasions one month apart, and another cat 
was initially found to have mixed infection (assemblages A and F) and then 
found to be infected only with assemblage F one month later. In all other 
cases (n = 3) where multiple positive results were obtained for a single cat 
using the ELISA, assemblage results were not obtainable on subsequent 
samples (e.g. PCR negative). This occurred with both host-adapted and 
potentially zoonotic assemblages and may be due to false positive results that 
have been reported to occur with the SNAP® Giardia Test following treatment 
(personal communication, IDEXX technical services). Alternatively, this may 
have been due to problems with the PCR (e.g. false negatives) rather than 
with the ELISA (e.g. false positives). Historically it has been difficult to amplify 
DNA extracted from fecal material, due to insufficient quantity or poor quality 
of the DNA in combination with the presence of inhibitors.27 Although it was 
not possible to determine whether the negative PCR results were accurate, 
cats for which assemblage was not determined were excluded from the 
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analysis out of necessity. Because the inability to determine the assemblage 
types seemed to be random, we believe that we did not introduce bias to the 
analysis by deleting these missing results, but it is possible that one or more of 
the risk factors were directly influenced by this decision. 
It is possible that other risk factors for Giardia infection or differences in 
assemblage type exist but were not detected. One reason for this may be due 
to selection bias, in that only cats available for adoption in one shelter were 
sampled. Cats in this facility spend a varying amount of time (one day to 
several months) in other areas of the shelter and may have been treated for a 
number of conditions, including Giardia, prior to being made available for 
adoption. Sampling these cats as they entered the shelter may have resulted 
in the identification of different risk factors for infection, but cats available to 
the public for adoption were chosen for this study as we considered them to be 
the best population in which to investigate potential for public health risk.  
Additionally, there may be different risk factors for cats in other animal shelters 
with shorter lengths of stay or different housing. All attempts were made to 
sample as many cats as possible, but the sample size coupled with a relatively 
low prevalence reduced the power to detect significant differences.  Because 
of the cross-sectional nature of the study, the prevalence estimates reported 
here represent only detection of Giardia at the point of sampling and do not 
provide any indication of duration or persistence of infection.  
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Conclusion 
The monthly prevalence of Giardia infection reported in this study is 
comparable to that reported by other investigators, with variations depending 
on the population studied and the diagnostic methods used. Stray adult cats 
and those with outdoor access were more likely to be infected than owner-
surrendered cats and those that were kept indoors only.  Cats in colony 
housing, particularly at high densities and for prolonged periods of time, may 
also be more likely to be shedding Giardia cysts although these did not retain 
their significance in the multivariable model. Although group housing may 
increase shelter cats’ exposure to parasitic and infectious disease in certain 
cases, the benefits of stress reduction and improved physical and behavioral 
health may outweigh such risks. Furthermore, shelters can reduce that risk 
with disease surveillance systems and prompt removal and isolation of any cat 
with signs of an infectious disease.  Further research is needed to better 
understand the impact housing style has on Giardia infection in shelter cats. 
The majority of cats were not infected with assemblages that are thought to 
have zoonotic potential.  Kittens were particularly unlikely to be infected with 
the assemblages A and B.  However, 25% of cats were found to have an 
assemblage A, B, or a mixed A/F infection and these cats were more likely to 
have soft stools or diarrhea than cats infected with assemblage F.  Thus, the 
potential that cats may be a source of human Giardia infection can not be 
discounted. Unfortunately, identification of cats that could pose a risk is not 
possible without advanced molecular diagnostics.  To date, insufficient data 
has been collected on the assemblage types found in Giardia infected cats to 
make an accurate, quantitative assessment of the public health risk associated 
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with these cats.  Despite a greater understanding of the molecular 
epidemiology of the disease, the question as to whether or not asymptomatic 
cats found to be shedding Giardia cysts should be treated in order to protect 
public health cannot be answered. This paucity of knowledge makes evidence-
based decision-making difficult if not impossible in the clinical setting. In the 
context of animal shelters, where large numbers of cats of varying immune 
status are housed concurrently and where resources for animal care are 
limited, these challenges are particularly evident. Further work is needed with 
larger numbers of cats, both owned and from animal shelters, and from 
various geographic locations to better understand the importance of various 
risk factors and to establish the true zoonotic potential of Giardia. 
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